# Angiotensin II for Distributive Shock

> **NCT04904562** · PHASE4 · TERMINATED · sponsor: **Northwestern University** · enrollment: 2 (actual)

## Conditions studied

- Distributive Shock

## Interventions

- **DRUG:** Angiotensin II
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04904562
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Enrollment Challenges
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904562, "Angiotensin II for Distributive Shock". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04904562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*